Thermo Fisher price target raised to $135 from $110 at RW Baird Baird raised its price target on Thermo Fisher and calls it a top large-cap pick for 2014. The firm cited improving end-markets, strong execution, and easing comparisons. Shares are Outperform rated.
NIH draft FY16 funding budget better than expected at BofA/Merrill Last night, the House Appropriations Labor/Health and Human Services Subcommittee released its draft FY16 funding budget. The bill proposed a FY16 funding increase of 3% for the National Institute of Health, versus BofA/Merrill's forecast for a 1% increase. The firm said the proposed boost in funding would be a positive for the Life Sciences & Tools sector, especially iIllumina (ILMN) and Thermo Fisher (TMO) which have the most exposure.